Cargando…
Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is one of the most lethal subtypes of breast cancer (BC), and it accounts for approximately 10%–20% of all invasive BCs diagnosed worldwide. The survival rate of TNBC in stages III and IV is very low, and a large number of patients are diagnosed in these stages....
Autores principales: | Alam, Md Shahin, Sultana, Adiba, Wang, Guanghui, Haque Mollah, Md Nurul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768339/ https://www.ncbi.nlm.nih.gov/pubmed/36567949 http://dx.doi.org/10.3389/fmolb.2022.1049741 |
Ejemplares similares
-
Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies
por: Alam, Md. Shahin, et al.
Publicado: (2022) -
Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents
por: Horaira, Md Abu, et al.
Publicado: (2023) -
New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
por: Fu, Yeqin, et al.
Publicado: (2023) -
Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
por: Green-Tripp, Gabriela, et al.
Publicado: (2022) -
The application of exosomes in the treatment of triple-negative breast cancer
por: Weaver, John W., et al.
Publicado: (2022)